Intestive®
Research Shorts
Intestive®
is backed by a 40-year history of safe clinical use.
(1,4,5)
Proven
safe. All natural, drug-free, and with no known side
effects, drug interactions, or contraindications.
(1,2,3,5)
Intestive®
provides intestinal support without the inconvenient
or uncomfortable side effects associated with some
OTC remedies and pharmaceutical attempts. (2,3)
Safety,
tolerance, and benefit of 1 to 2g dosages of the peptides
both orally and by tube feeding were demonstrated
in one study of 2500 premature, malnourished infants
and another study of 3200 malnourished children. (1,5)
A
select committee of the Food and Nutrition Board of
the U.S. National Academy of Sciences has previously
endorsed the safety and effectiveness of a concentrate
of protein from fish, such as that found in Intestive®.
(6)
In
a controlled study, a team of physicians and surgeons
found the peptides in Intestive® to be a superior
source of protein compared to a casein standard for
hospitalized patients, and further noted that the
positive results in patients went beyond what thought
could be related simply to protein. (5)
Intestive®
was reported to reduce the symptoms of occasional
diarrhea and constipation, and alleviate bloating,
gas, and symptoms generally viewed as gas at a dosage
of 3g per day for 60 days, as reported in a recent
study. (2)
In
an early study, the intake of the hydrolyzed protein
in Intestive® assisted recovery in hospitalized patients
with diarrhea. (5)
The
3rd International Forum of Pediatric Gastroenterology
and Nutrition in Brazil recommended the use of the
hydrolyzed protein in Intestive® in cases of diarrhea.
(5)
3g
per day of Intestive® over 30 days strengthened intestinal
integrity as assessed by laboratory testing in a recent
study that also monitored function and improvement
in symptoms. (3)
Numerous
clinical studies performed in hospitals over the past
40 years have demonstrated the range of benefits provided
by the peptide base in Intestive®, including not only
improvement in protein balance and intestinal function,
but also in related areas of maintaining immune system
function, healthy blood profiles, and general health
among patients ranging from infants to geriatrics.
(1,5)
In
several studies with immune compromised children,
2 to 3g per day of the peptides in Intestive® resulted
in maintaining normal immunoglobulin levels (antibodies
against infection) and a general support to the clinical
management against infection. (1,5)
Two
adult groups, one between 30 and 60 years of age and
one between 60 and 80 years of age, demonstrated healthy
blood profiles over a 3 month period at 3g of the
peptides in Intestive® per day, as part of a longitudinal
follow up study. (5)
In
a controlled study, the peptides in Intestive® were
tested against the standard protein used in tube feeding
of surgical patients. Results with the peptides in
Intestive® were superior in the areas of blood variables,
skin and muscle tone, nitrogen balance, and general
metabolism. (5)
References
- Delfino
AH. Nutrition Education and Food Science Technology.
BPC: A fish protein concentrate for human consumption.
Nutrition and Food Science: Present Knowledge
and Utilizaiton. New York: Plenum Press. 1980;2:249-67.
- Englender
C. Symptom reduction in irritable bowel syndrome
with pre-digested fish protein supplement. Townsend
Letter. 2000;205/206:60-4.
- Nichols
TW. Unpublished research results. Analyses by Great
Smokies Diagnostic Laboroatory. Asheville, NC; 800-522-4762.
- Pariser
ER, Wallerstein MB, Corkery CJ, et al. Fish protein
concentrate: Panacea for protein malnutrition?
The MIT Press;1978:78-9.
- Scientific
Division Monograph, compiled by Victor Bertullo;1980.
- Snyder
DG. Personal Communication.
|